Legend Biotech CFO sells 5,430 shares for taxes

The sale covered shares used to satisfy withholding tax obligations upon vesting of restricted share units.

Available on EDGAR 09/23/2026 - 04:16 PM EDT Accepted by SEC EDGAR 09/23/2026 - 04:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Legend Biotech Corp Chief Financial Officer Carlos E. Santos received a grant of 19,676 Ordinary Shares on September 21, 2026. That same day, Santos sold 5,430 Ordinary Shares at a weighted average price of $9.14 per share to satisfy withholding tax obligations upon vesting of restricted share units; sale prices ranged from $8.905 to $9.325 per share. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 5,430 shares

Net Sell 2 txns

Insider Santos Carlos E

Role Chief Financial Officer

Sold 5,430 shs ($50K)

Share of Position Sold 27.6%

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	19,676	$0.00	$0.00
Sale	Ordinary Shares F1, F2, F3	5,430	$9.14	$50K

Holdings After Transaction: Ordinary Shares — 14,246 shares (Direct)

Holdings Before and After: Ordinary Shares, 0 to 14,246 shares (Direct)

Footnotes (3)

1. F1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
2. F2. Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.
3. F3. The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

Key Figures

Shares granted: 19,676 Ordinary Shares Shares sold: 5,430 Ordinary Shares Weighted average sale price: $9.14 per Ordinary Share +1 more

4 metrics

Shares granted 19,676 Ordinary Shares Grant to Chief Financial Officer Carlos E. Santos on September 21, 2026

Shares sold 5,430 Ordinary Shares Sale to satisfy withholding tax obligations upon vesting of restricted share units on September 21, 2026

Weighted average sale price $9.14 per Ordinary Share Sale on September 21, 2026

Sale price range $8.905 to $9.325 per Ordinary Share Reported prices for the September 21, 2026 sale

Key Terms

restricted share units, weighted average price, withholding tax obligations, American Depositary Shares

4 terms

restricted share units financial

"upon the vesting of restricted share units"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

withholding tax obligations financial

"sold to satisfy withholding tax obligations"

American Depositary Shares financial

"Each ADS represents two ordinary shares of the Issuer."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LEGN shares did the CFO receive and sell?

Carlos E. Santos received a grant of 19,676 Ordinary Shares and sold 5,430 Ordinary Shares on September 21, 2026. The sale was to satisfy withholding tax obligations upon vesting of restricted share units.

What price did the LEGN CFO receive for the share sale?

The 5,430 Ordinary Shares were sold at a weighted average price of $9.14 per share on September 21, 2026. Reported sale prices ranged from $8.905 to $9.325 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Santos Carlos E

(Last) (First) (Middle)

C/O LEGEND BIOTECH CORP

77 CORPORATE DRIVE, 4TH FLOOR

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Legend Biotech Corp [ LEGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	09/21/2026		A		19,676	A	$0	19,676	D
Ordinary Shares(1)	09/21/2026		S		5,430(2)	D	$9.14(3)	14,246	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

2. Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.

3. The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

	/s/ Robert Staloff, Attorney-in-Fact	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)